Browse Arkansas Code titles and sections
21 U.S.C. § 360fff — Definitions
Federal law — U.S. Code and appendices · legal_authorities
Page 472
TITLE 21—FOOD AND DRUGS
§ 360fff
PART I—NONPRESCRIPTION SUNSCREEN AND
OTHER ACTIVE INGREDIENTS
TERMINATION OF PART
This part ceased to be effective at the end of
fiscal year 2022, see section 360fff–8 of this title.
§ 360fff. Definitions
In this part—
(1) the term ‘‘Advisory Committee’’ means
the Nonprescription Drug Advisory Committee
of the Food and Drug Administration or any
successor to such Committee;
(2) the term ‘‘final sunscreen order’’ means
an order published by the Secretary in the
Federal Register containing information stat-
ing that a nonprescription sunscreen active in-
gredient or combination of nonprescription
sunscreen active ingredients—
(A) is GRASE and is not misbranded if
marketed in accordance with such order; or
(B) is not GRASE and is misbranded;
(3) the term ‘‘GRASE’’ means generally rec-
ognized, among experts qualified by scientific
training and experience to evaluate the safety
and effectiveness of drugs, as safe and effective
for use under the conditions prescribed, rec-
ommended, or suggested in the labeling of a
drug as described in section 321(p) of this title;
(4) the term ‘‘GRASE determination’’ means,
with respect to a nonprescription active ingre-
dient or a combination of nonprescription ac-
tive ingredients, a determination of whether
such ingredient or combination of ingredients
is GRASE;
(5) the term ‘‘nonprescription’’ means not
subject to section 353(b)(1) of this title;
(6) the term ‘‘pending request’’ means each
request with respect to a nonprescription sun-
screen active ingredient submitted under sec-
tion 330.14 of title 21, Code of Federal Regula-
tions (as in effect on November 26, 2014) for
consideration for inclusion in the over-the-
counter drug monograph system—
(A) that was dete
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 360fff
Stored review status: historical_2024_not_currentness_verified. A text match is a research starting point; applicability is not established.
Original supplied file — preserved unchanged
Download original Markdown file
File SHA-256: 9513b034391e7be640a45e5678b38fb24ecef3a420708dd112f844f49fa4ce0c. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Open the recorded source website ↗
Record provenance
Stable record: federal_law:legal_authorities:usc2024-2f7820144c3cf4fb2fbd9768
Source file: Laws/federal/codes/united-states-code-2024/title-21/section-360fff-definitions--b8482a7532.md
Pages: Not recorded – Not recorded
Passage SHA-256: 68395728336f5e23dee0a8292f5094575d9dd88592f13cc485bbea5083654507
Source location: USCODE-2024-title21-chap9-subchapV-partI-sec360fff.pdf
Stored source content
Page 472
TITLE 21—FOOD AND DRUGS
§ 360fff
PART I—NONPRESCRIPTION SUNSCREEN AND
OTHER ACTIVE INGREDIENTS
TERMINATION OF PART
This part ceased to be effective at the end of
fiscal year 2022, see section 360fff–8 of this title.
§ 360fff. Definitions
In this part—
(1) the term ‘‘Advisory Committee’’ means
the Nonprescription Drug Advisory Committee
of the Food and Drug Administration or any
successor to such Committee;
(2) the term ‘‘final sunscreen order’’ means
an order published by the Secretary in the
Federal Register containing information stat-
ing that a nonprescription sunscreen active in-
gredient or combination of nonprescription
sunscreen active ingredients—
(A) is GRASE and is not misbranded if
marketed in accordance with such order; or
(B) is not GRASE and is misbranded;
(3) the term ‘‘GRASE’’ means generally rec-
ognized, among experts qualified by scientific
training and experience to evaluate the safety
and effectiveness of drugs, as safe and effective
for use under the conditions prescribed, rec-
ommended, or suggested in the labeling of a
drug as described in section 321(p) of this title;
(4) the term ‘‘GRASE determination’’ means,
with respect to a nonprescription active ingre-
dient or a combination of nonprescription ac-
tive ingredients, a determination of whether
such ingredient or combination of ingredients
is GRASE;
(5) the term ‘‘nonprescription’’ means not
subject to section 353(b)(1) of this title;
(6) the term ‘‘pending request’’ means each
request with respect to a nonprescription sun-
screen active ingredient submitted under sec-
tion 330.14 of title 21, Code of Federal Regula-
tions (as in effect on November 26, 2014) for
consideration for inclusion in the over-the-
counter drug monograph system—
(A) that was determined to be eligible for
such review by publication of a notice of eli-
gibility in the Federal Register prior to No-
vember 26, 2014; and
(B) for which safety and effectiveness data
have been submitted to the Secretary prior
to November 26, 2014;
(7) the term ‘‘proposed sunscreen order’’
means an order containing a tentative deter-
mination published by the Secretary in the
Federal Register containing information pro-
posing that a nonprescription sunscreen active
ingredient or combination of nonprescription
sunscreen active ingredients—
(A) is GRASE and is not misbranded if
marketed in accordance with such order;
(B) is not GRASE and is misbranded; or
(C) is not GRASE and is misbranded be-
cause the data are insufficient to classify
such ingredient or combination of ingredi-
ents as GRASE and not misbranded and ad-
ditional information is necessary to allow
the Secretary to determine otherwise;
(8) the term ‘‘sponsor’’ means the person
that submitted—
(A) a request under section 360fff–1 of this
title;
(B) a pending request; or
(C) any other application subject to this
part;
(9) the term ‘‘sunscreen’’ means a drug con-
taining one or more sunscreen active ingredi-
ents; and
(10) the term ‘‘sunscreen active ingredient’’
means an active ingredient that is intended
for application to the skin of humans for pur-
poses of absorbing, reflecting, or scattering ul-
traviolet radiation.
(June 25, 1938, ch. 675, § 586, as added Pub. L.
113–195, § 2(a), Nov. 26, 2014, 128 Stat. 2035.)
Statutory Notes and Related Subsidiaries
CONSTRUCTION
Pub. L. 113–195, § 2(b), Nov. 26, 2014, 128 Stat. 2045, pro-
vided that: ‘‘Nothing in the amendment made by this
section [enacting this section and sections 360fff–1 to
[former] 360fff–5 of this title] shall be construed to—
‘‘(1) limit the right of a sponsor (as defined in sec-
tion 586(8) of the Federal Food, Drug, and Cosmetic
Act [21 U.S.C. 360fff(8)], as added by subsection (a)) to
request that the Secretary of Health and Human
Services convene an advisory committee; or
‘‘(2) limit the authority of the Secretary of Health
and Human Services to meet with a sponsor (as de-
fined in section 586(8) of the Federal Food, Drug, and
Cosmetic Act, as added by subsection (a)).’’
§ 360fff–1. Submission of requests
Any person may submit a request to the Sec-
retary for a determination of whether a non-
prescription sunscreen active ingredient or a
combination of nonprescription sunscreen active
ingredients, for use under specified conditions,
to be prescribed, recommended, or suggested in
the labeling thereof (including dosage form, dos-
age strength, and route of administration) is
GRASE and should be included in part 352 of
title 21, Code of Federal Regulations (or any suc-
cessor regulations) concerning nonprescription
sunscreen.
(June 25, 1938, ch. 675, § 586A, as added Pub. L.
113–195, § 2(a), Nov. 26, 2014, 128 Stat. 2036.)
§ 360fff–2. Eligibility determinations; data sub-
mission; filing
(a) Eligibility determinations
(1) In general
Not later than 60 calendar days after the
date of receipt of a request under section
360fff–1 of this title, the Secretary shall—
(A) determine, in accordance with para-
graph (2), whether the request is eligible for
further review under subsection (b) and sec-
tion 360fff–3 of this title;
(B) notify the sponsor of the determina-
tion of the Secretary; and
(C) make such determination publicly
available in accordance with paragraph (3)
and subsection (b)(1).
(2) Criteria for eligibility
(A) In general
To be eligible for review under subsection
(b) and section 360fff–3 of this title, a request
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
In this part—
(1) the term “Advisory Committee” means the Nonprescription Drug Advisory Committee of the Food and Drug Administration or any successor to such Committee;
(2) the term “final sunscreen order” means an order published by the Secretary in the Federal Register containing information stating that a nonprescription sunscreen active ingredient or combination of nonprescription sunscreen active ingredients—
(A) is GRASE and is not misbranded if marketed in accordance with such order; or
(B) is not GRASE and is misbranded;
(3) the term “GRASE” means generally recognized, among experts qualified by scientific training and experience to evaluate the safety and effectiveness of drugs, as safe and effective for use under the conditions prescribed, recommended, or suggested in the labeling of a drug as described in [section 321(p) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section321/p&num=0&edition=prelim);
(4) the term “GRASE determination” means, with respect to a nonprescription active ingredient or a combination of nonprescription active ingredients, a determination of whether such ingredient or combination of ingredients is GRASE;
(5) the term “nonprescription” means not subject to [section 353(b)(1) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section353/b/1&num=0&edition=prelim);
(6) the term “pending request” means each request with respect to a nonprescription sunscreen active ingredient submitted under section 330.14 of title 21, Code of Federal Regulations (as in effect on November 26, 2014) for consideration for inclusion in the over-the-counter drug monograph system—
(A) that was determined to be eligible for such review by publication of a notice of eligibilit
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 360fff
Stored review status: release_metadata_unconfirmed. Same stored citation; legal effect and authority still require review.